每年專案
個人檔案
學歷
- 2006-2008 臺北醫學大學臨床醫學研究所碩士
- 1990-1997 臺北醫學大學醫學系學士
經歷
- 衛生福利部雙和醫院病理科主任
- 2020.05- 臺北醫學大學醫學系病理學科助理教授
- 2012.08-2013.07 美國布朗大學婦幼醫院病理部研究及訪問學者
- 2008.02-2020.05 臺北醫學大學醫學系病理學科講師
- 衛生福利部雙和醫院病理科主治醫師
- 2007.11-2011.01 臺北醫學大學附設醫院病理科專任主治醫師
- 2003.06-2007.10 財團法人恩主公醫院主治醫師
- 2002.12-2003.05 臺北醫學大學附設醫院主治醫師
- 1998.03-2002.11 臺北醫學大學附設醫院住院醫師
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
專案
- 2 已完成
-
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor
Chen, L. Y., Shen, Y. A., Chu, L. H., Su, P. H., Wang, H. C., Weng, Y. C., Lin, S. F., Wen, K. C., Liew, P. L. & Lai, H. C., 6月 2024, 於: Antioxidants. 13, 6, 735.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
Correction to: In vitro drug testing using patient-derived ovarian cancer organoids (Journal of Ovarian Research, (2024), 17, 1, (194), 10.1186/s13048-024-01520-2)
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., 12月 2024, 於: Journal of Ovarian Research. 17, 1, 243.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
In vitro drug testing using patient-derived ovarian cancer organoids
Chen, L. Y., Chou, Y. T., Liew, P. L., Chu, L. H., Wen, K. C., Lin, S. F., Weng, Y. C., Wang, H. C., Su, P. H. & Lai, H. C., 12月 2024, 於: Journal of Ovarian Research. 17, 1, 194.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus) -
The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes
Chen, L. Y., Chen, H. Y., Lai, H. C., Lin, S. F., Wen, K. C., Darmawi & Liew, P. L., 2024, (接受/付印) 於: Taiwanese Journal of Obstetrics and Gynecology. 64, 1, p. 110-119 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Pulmonary lymphoepithelioma-like carcinoma: A complication of Epstein–Barr virus in a teenager
Chen, S. H., Miser, J. S., Liew, P. L., Chen, B. J. & Liu, Y. L., 8月 2023, 於: Journal of Microbiology, Immunology and Infection. 56, 4, p. 886-888 3 p.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取1 引文 斯高帕斯(Scopus)
資料集
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
資料集: Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
資料集: Dataset